- Filed
- May 8, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2020 · Mar 31, 2020 | 47.9M sh |
| Shares Diluted | Q3 2020 · Mar 31, 2020 | 49.02M sh |
| Shares Diluted | Q3 2020 · Mar 31, 2019 | 45.59M sh |
| Shares Diluted | Q3 2020 · Mar 31, 2019 | 45.35M sh |
| Shares Outstanding | Q3 2020 · Mar 31, 2020 | 47.29M sh |
| Stock Repurchased | Q3 2020 · Mar 31, 2020 | $5.3M |
| Stock Repurchased | Q3 2020 · Mar 31, 2020 | $9.35M |
| Stock Repurchased | Q3 2020 · Mar 31, 2019 | $1.3M |
| Capex | Q3 2020 · Mar 31, 2020 | $1.32M |
| Capex restated | Q3 2020 · Mar 31, 2019 | $956K |
| Operating Cash Flow | Q3 2020 · Mar 31, 2020 | $41.68M |
| Operating Cash Flow restated | Q3 2020 · Mar 31, 2019 | $6.19M |
| Short Term Investments | Q3 2020 · Mar 31, 2020 | $107.27M |
| Short Term Investments | Q3 2020 · Jun 30, 2019 | $72.2M |
| Cash And Equivalents | Q3 2020 · Mar 31, 2020 | $16.48M |
| Cash And Equivalents | Q3 2020 · Jun 30, 2019 | $27.28M |
| Cash And Equivalents | Q3 2020 · Mar 31, 2019 | $21.25M |
| Stockholders Equity | Q3 2020 · Mar 31, 2020 | $101.91M |
| Stockholders Equity | Q3 2020 · Dec 31, 2019 | $106.48M |
| Stockholders Equity | Q3 2020 · Sep 30, 2019 | $96.14M |
| Stockholders Equity | Q3 2020 · Jun 30, 2019 | $90.64M |
| Stockholders Equity | Q3 2020 · Mar 31, 2019 | $93.9M |
| Stockholders Equity | Q3 2020 · Dec 31, 2018 | $99.43M |
| Stockholders Equity | Q3 2020 · Sep 30, 2018 | $102.28M |
| Stockholders Equity | Q3 2020 · Jun 30, 2018 | $108.88M |
| Current Liabilities | Q3 2020 · Mar 31, 2020 | $107.83M |
| Current Liabilities | Q3 2020 · Jun 30, 2019 | $100.4M |
| Current Assets | Q3 2020 · Mar 31, 2020 | $200.44M |
| Current Assets | Q3 2020 · Jun 30, 2019 | $200.08M |
| Total Assets | Q3 2020 · Mar 31, 2020 | $315.55M |
| Total Assets | Q3 2020 · Jun 30, 2019 | $297.02M |
| Eps Diluted | Q3 2020 · Mar 31, 2020 | −$0.02 |
| Eps Diluted | Q3 2020 · Mar 31, 2020 | $0.17 |
| Eps Diluted | Q3 2020 · Mar 31, 2019 | −$0.16 |
| Eps Diluted | Q3 2020 · Mar 31, 2019 | −$0.43 |
| Eps Basic | Q3 2020 · Mar 31, 2020 | −$0.02 |
| Eps Basic | Q3 2020 · Mar 31, 2020 | $0.17 |
| Eps Basic | Q3 2020 · Mar 31, 2019 | −$0.16 |
| Eps Basic | Q3 2020 · Mar 31, 2019 | −$0.43 |
| Sga Expense | Q3 2020 · Mar 31, 2020 | $6.4M |
| Sga Expense | Q3 2020 · Mar 31, 2020 | $20.12M |
| Sga Expense | Q3 2020 · Mar 31, 2019 | $5.52M |
| Sga Expense | Q3 2020 · Mar 31, 2019 | $16.69M |
| Rd Expense | Q3 2020 · Mar 31, 2020 | $21.62M |
| Rd Expense | Q3 2020 · Mar 31, 2020 | $62M |
| Rd Expense restated | Q3 2020 · Mar 31, 2019 | $19.32M |
| Rd Expense restated | Q3 2020 · Mar 31, 2019 | $55.58M |
| Net Income | Q3 2020 · Mar 31, 2020 | −$733K |
| Net Income | Q3 2020 · Mar 31, 2020 | $8.32M |
| Net Income | Q3 2020 · Dec 31, 2019 | $13.01M |
| Net Income | Q3 2020 · Sep 30, 2019 | −$3.95M |
| Net Income | Q3 2020 · Mar 31, 2019 | −$7.48M |
| Net Income | Q3 2020 · Mar 31, 2019 | −$19.63M |
| Net Income | Q3 2020 · Dec 31, 2018 | −$4.58M |
| Net Income | Q3 2020 · Sep 30, 2018 | −$7.57M |
| Operating Income | Q3 2020 · Mar 31, 2020 | −$1.21M |
| Operating Income | Q3 2020 · Mar 31, 2020 | $10.54M |
| Operating Income restated | Q3 2020 · Mar 31, 2019 | −$5.92M |
| Operating Income restated | Q3 2020 · Mar 31, 2019 | −$17.4M |
| Gross Profit | Q3 2020 · Mar 31, 2020 | $28.97M |
| Gross Profit | Q3 2020 · Mar 31, 2020 | $98.9M |
| Gross Profit restated | Q3 2020 · Mar 31, 2019 | $21.09M |
| Gross Profit restated | Q3 2020 · Mar 31, 2019 | $61.06M |
| Revenue | Q3 2020 · Mar 31, 2020 | $64.5M |
| Revenue | Q3 2020 · Mar 31, 2020 | $205M |
| Revenue restated | Q3 2020 · Mar 31, 2019 | $48.54M |
| Revenue restated | Q3 2020 · Mar 31, 2019 | $144.95M |